Bin Xia

Bin Xia

Auto-generated profile, based on publicly available information

Bin Xia

Clinical Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
CLChuqian Lei
Chuqian Lei
CYCiqiu Yang
Ciqiu Yang
BXBin Xia
Bin Xia
FJFei Ji
Fei Ji
YZYi Zhang
Yi Zhang
KWKun Wang
Kun Wang
Lei C, et al. J Breast Cancer. 2019 Nov;23:e11. https://doi.org/10.4048/jbc.2020.23.e11

1 January 2020 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
CLChuqian Lei
Chuqian Lei
CYCiqiu Yang
Ciqiu Yang
BXBin Xia
Bin Xia
FJFei Ji
Fei Ji
YZYi Zhang
Yi Zhang
KWKun Wang
Kun Wang
Lei C, et al. J Breast Cancer. 2020 Apr;23(2):230-231. https://doi.org/10.4048/jbc.2020.23.e19

3 November 2026 in Microbiology Spectrum
Verified
Journal Article
Open access
LSLijun Shen
Lijun Shen
YHYunxing He
Yunxing He
KWKai Wang
Kai Wang
ZZZhen Zhang
Zhen Zhang
YWYaqing Wen
Yaqing Wen
TCTingjin Chen
Tingjin Chen
Intestinal Staphylococcus aureus colonization in type 2 diabetes mellitus (T2DM) remains poorly defined with respect to prevalence, clinical associations, and molecular characteristics. We investigated intestinal S. aureus colonization in 142 patients with T2DM and characterized the recovered isolates using antimicrobial susceptibility testing, resistance gene profiling, multilocus sequence typing, accessory gene regulator typing, spa typing, and whole-genome sequencing. Clinical and laboratory characteristics were compared between colonized and non-colonized patients, and siderophore production and biofilm formation were evaluated in major molecular types. S. aureus colonization was identified in 30 patients (21.1%, 95% confidence interval: 15.2%–28.6%) based on a single fecal sample per patient, including one methicillin-resistant isolate. Isolates remained highly susceptible to most tested antimicrobials, except penicillin. The β-lactamase gene blaZ was the most prevalent resistance determinant (83.3%). MLST revealed a polyclonal population dominated by ST15 (30.0%), ST1156 (26.7%), and ST5 (26.7%), with agr II (56.7%) and spa type t84 (43.3%) being the most common types. Whole-genome sequencing further demonstrated distinct plasmid architectures between methicillin-susceptible S. aureus and methicillin-resistant S. aureus (MRSA) isolates and identified an SCCmec IVc (2B) element in the MRSA isolate. Siderophore production was significantly higher in ST15 and ST1156 than in ST5, whereas biofilm formation did not. These findings provide a comprehensive characterization of the clinical and epidemiological profiles of intestinal S. aureus colonization in patients with T2DM and highlight the need for continued genomic surveillance and mechanistic studies to support infection prevention and therapeutic strategies. IMPORTANCE: Intestinal Staphylococcus aureus colonization in type 2 diabetes mellitus (T2DM) has remained largely uncharacterized despite the well-documented heightened infection risk in this population. Here, we show that 21.1% (95% confidence interval: 15.2%–28.6%) of hospitalized T2DM patients harbor gut S. aureus (only 3.3% methicillin-resistant S. aureus [MRSA]). The isolates form a polyclonal population dominated by ST15, ST1156, and ST5, carry predominantly blaZ , and display lineage-specific differences in siderophore production—an iron-acquisition trait critical for gut persistence. These data establish the diabetic intestine as a clinically relevant reservoir, underscore the limitations of nares-only surveillance, and highlight the need for integrated genomic and mechanistic studies to guide infection prevention in T2DM.